Countdown to 2022 CBIIC:

Helena ZHANG

Chief Medical Officer, Convalife

Helena, MD, MBA is the Chief Medical Officer (CMO) of Convalife. Dr. Zhang joined the biopharmaceutical industry in 1996 and had gained a wealth of experience on product life-cycle management both in the field of drug and medical device in China and US. She was the Chief Medical Officer for Quintiles, now IQVIA in the Greater China region. She is familiar with the operation of domestic innovative drug companies and multinational companies. She has successfully led a number of new drug clinical development projects. Her rich experiences cover medical, clinical operation and study design etc. She served as the head of clinical and medical of Asia Pacific region in MNC pharmaceutical company and CRO such as Pierre Fabre medicament and Parexel. She also served as the key board member of the clinical research and drug safety committee of the Chinese Society of Clinical Oncology (CSCO). She wrote and published SCI papers, and served as the Chairman of Medical Science Liaison Committee, CMAO (Chinese Medical Affairs Organization). Dr. Zhang graduated from the medical school of Shanghai Jiaotong University and obtained a master of Business Administration (MBA) from Cardiff Business School in the UK. She practiced clinical medicine in the hospital. She worked in the medical center of Indiana University, US for four years and has been engaged in clinical development and medical affairs since returning home in 2006.